New clinical trial shows that Hofseth BioCare’s fresh salmon oil will best improve your cardiovascular health compared to other treated and concentrated Omega-3 oils.

In the blood, ox-LDL-GP is used as a marker for judging the risk for heart and cardiovascular diseases. Hofseth BioCare has through a series of studies shown that the daily intake of fresh unprocessed salmon oil reduces serum levels of ox-LDL-GP. This has been seen in context with the Omega-3 content.

In the blood, ox-LDL-GP is used as a marker for judging the risk for heart and cardiovascular diseases. Hofseth BioCare has though a series of studies shown that the daily intake of fresh unprocessed salmon oil reduces serum levels of ox-LDL-GP. This has been seen in context with the Omega-3 content.

A new mouse model study, published in The Journal of Functional Foods in Health and Disease (FFHD), has now considered the relationship between the content of Omega-3 and the reduction of ox-LDL-GP. It has also studied the context between with the freshness of the oil, and the processing normally used in the oil industry – like distilling, high temperatures and use of chemical reagents and solvents.

The study included seven groups, and one control group. Four groups received Hofseth BioCare’s fresh salmon oil with different values of Omega-3. The other three received the same oil with high levels of Omega-3, but that had been subject to high temperatures, chemical hydrolysis, standardized distilling process and oxidation respectively.

The results showed that the reduction of ox-LDL-GP was insignificant in the group that received lower levels of Omega-3, but at 80 mg daily dosage showed a reduction of 5 %. This reduction did not increase by doubling or tripling amount of EPA/DHA consumed.
In other words, to reduce ox-LDL-GP you need only a minimum of 80 mg EPA/DHA daily.

Exposing the oil to high temperatures reduced the effect by 20 %. Chemical treatment and distillation of the oil cancelled out the effect, and exposing the oil to oxidation halved the effect of reducing ox-LDL-GP.

The study documents that extensive treatment of fish oil will reduce the health benefits, despite that this is used to increase the levels of Omega-3. The study also shows that as little as 80 mg EPA/DHA will give a good enough health-effect regarding the reduction of risk for heart and cardiovascular wellbeing.

The best effect, next to eating the whole raw fish, for improving heart and cardiovascular wellbeing comes from consuming fresh oil with natural levels of Omega-3.

Source:
http://functionalfoodscenter.net/files/96846359.pdf